iTonic Holdings Ltd.
ITOC
NASDAQ·Healthcare·Medical - Specialties·Mkt cap $3.0M
$0.32
▲ +8.55%
P/E
—
Mkt Cap
$3.0M
52-Wk Range
$0.22–$1.15
52-Week Range
$0.22 - $1.15
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 27.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary FTTPS treatment planning technology with advanced dose optimization algorithms
- 25+ years of specialized expertise in brachytherapy and cancer treatment innovation
- Established market presence in Asia with potential for global expansion
- Regulatory-approved medical devices with clinical validation
Bear Case
1 risk
- High volatility (beta 2.8). Larger-than-normal price swings expected.
Growth
No forward estimates available
Increasing global demand for advanced cancer treatment technologies
Value
Valuation data unavailable
Momentum
Falling
-36.7% over 3m
Quality
Excellent
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying ITOC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Most recent quarter reported revenue of $10.0K (-68% YoY). Reported EPS of -$0.02. Gross margin 79.0%.
Reported EPS · last 4Q
Q2 25
-$0.02
Q4 24
-$0.00
Q2 24
-$0.00
Q4 23
-$0.00
Revenue trend · last 7Q
—
—
-31%
+24%
-21%
-34%
-68%
Q2 22
Q4 22
Q2 23
Q4 23
Q2 24
Q4 24
Q2 25
$57.2K
$43.2K
$39.4K
$53.5K
$31.1K
$35.1K
$10.0K
Margins · last 7Q
Gross
79.0%
Operating
—
Profit
-3018.2%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How ITOC stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related